





Because food was presumed to be the cause of the EGE based on
his history of multiple food allergy, he was started on elimination
diet therapy combined with an amino acid-based elemental diet
to compensate for protein deficiency. Soy, wheat, beef, pork, and
rice were eliminated in addition to the food previously elimi-
nated (eggs, milk, fish/shellfish, peanuts/tree nuts, chicken,
and sesame). Additionally, he continued to take pranlukast and
cetirizine. Although his abdominal pain promptly resolved, his pe-
ripheral eosinophilia persisted. We stared administrating 15 mg
per day (0.88 mg/kg/day) of oral prednisolone 13 days after
starting the elimination diet. Because prednisolone quickly im-
proved his eosinophilia, we gradually decreased it by 5 mg per week
and completed the regimen in 3 weeks. The reintroduction of soy
was performed 5 weeks after admission. He was able to eat 40 g of
Natto per day without any symptoms for 2 weeks. Nevertheless, his
abdominal pain and elevation of eosinophilia (3350/mm3) recurred
in 3 days after increasing Natto to 120 g per day. Rice and wheat
were reintroduced without any symptoms ; however, pork caused
abdominal pain and peripheral eosinophilia. Based on the recur-
rence of abdominal pain and peripheral eosinophilia, soy and pork
were identified as the foods causative of EGE in this case. His
heightincreased to 113.1 cm (-2.5 SD) and his serum albumin level
normalized to 4.2 g/dL 6 months after starting the dietary interven-
tion. OFCs with fish (yellowtail) and chicken were also performed to
screen for ingestible foods containing animal proteins ; immediate
allergic reactions appeared. Conjunctival edema and cough oc-
curred 1 min after ingesting 5 g of fish. Pain in the oral cavity and
pruritus of the face occurred 4 min after ingesting 3 g of chicken. He
has continued the elimination diet and the amino acid-based ele-
mental diet, and his abdominal symptoms have been under control.
DISCUSSION
The pathology of EGIDs, including that of EGE, remains un-
known. EGIDs are assumed to be diseases that cause dysfunction
and stenosis of the gastrointestinal tract as a result of excessive
immune responses against food or aeroallergens in the gastroin-
testinal mucosa with subsequent eosinophilic inflammation. The
skin prick test and serum-specific IgE test are often utilized to
Fig. 1. Findings of gastrointestinal endoscopy and histology of biopsy
specimen
The mucous of the gastric angle shows a rough, slightly erythematous,
and friable appearance (A). The biopsy findings of both the gastric angle
(B) and duodenum (C) show eosinophilic infiltration (20 eosinophils
per high-power field) into the mucosal layer (hematoxylin and eosin
staining, ×200)
Fig.2. Clinical course of the case
GI endoscopy, gastrointestinal endoscopy ; OFC, oral food challenge
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assess allergens causative of EGIDs (4). However, the involve-
ment of T cell -mediated immune responses and Th2 cytokines,
such as IL-5 and IL-13, has been reported to be more important
than the direct involvement of IgE in the pathogenesis of EGIDs
(5, 6), and EGID symptoms show delayed hypersensitive responses,
lacking typical immediate responses (3). Additionally, 44%-63% of
patients with EGIDs have other comorbid allergic conditions,
such as atopic dermatitis, food allergy, asthma, and/or allergic
rhinitis (7, 8), suggesting that they have already been sensitized to
plural foods and/or aeroallergens. Therefore, it is not trivial to
identify causative allergens in patients with EGIDs.
The utility of 6-FED in EGE has been controversial ; however,
the effect of 6-FED in improving EGE symptoms has been reported
(9, 10). In our case, elimination diet therapy (i.e., eliminating 6-
FED, beef, pork, chicken, rice, and sesame) was effective in im-
proving the symptoms, and subsequent reintroduction was useful in
identifying the EGE-causative foods. Our case is an example of the
forced removal of multiple foods in addition to specific causative
foods due to their potential of IgE-mediated allergic symptoms.
Proper dietary management over a long period is necessary to
improve the patient’s malnutrition and promote his physical devel-
opment.
In our case, the foods allowed for ingestion based on negative
OFC results induced EGE. We identified soy and pork as foods
responsible for the development of EGE in this case. The patient
showed oral tolerance to soy, and administration of low amounts of
Natto did not cause abdominal pain or eosinophilia ; however,
he remained intolerant to pork. In immediate-type food allergy,
allergic symptoms are induced by ingesting causative food in
amounts exceeding the threshold for allergy, i.e., in a dose-
dependent manner. The usefulness of low-dose oral immunother-
apy (OIT) for immediate-type food allergy has been previously
reported (11). However, the onset of EGE/EE has been reported in
OIT for the continuous ingestion of causative foods at high doses
(12-14). Cell-mediated immunity is induced by the continuous
ingestion of food allergens (15), and induction of allergen-specific
lymphocytes causes gastrointestinal mucosal disorders (16).
Sustained exposure to high doses of food allergens may trigger
EGE onset.
As with soy in our case, the dose-dependent onset of EGE has
been reported in a case with positive egg white-IgE (17). It is
considered that EGE is a disease involving both the humoral and
cell-mediated immunities against food allergens. Although it
remains a matter of speculation, a pathogenic condition may be
expressed as humoral immune-dominant EGE, which may pre-
sent a dose-dependent pattern of EGE onset.
Although the principle of the management of IgE-mediated food
allergy is the minimum elimination of causative food based on
accurate diagnosis including OFCs, the possibility of inducing
EGE due to continuing ingestion of the food even at amounts not
showing immediate allergic symptoms in OFCs should be consid-
ered. Because the risk factors for EGE in patients with food allergy
have not been clarified, further studies are necessary for the com-
prehensive management of food allergy.
The pharmacological treatment of EGE is performed in pa-
tients for whom elimination diet therapy is ineffective or infeasi-
ble. Corticosteroids are first-line anti-inflammatory drugs (1, 4).
Although corticosteroids improve symptoms in most patients with
EGE, they often relapse with the reduction or termination of the
steroids (18). Consequently, the long-term administration of steroids
is sometimes needed. In pediatric patients in particular, the side
effects of steroids, such as growth suppression and osteoporosis,
should be considered in addition to nutritional status. With re-
gard to other pharmacotherapy for EGE, the utility of leukotriene
receptor antagonists, histamine H1 receptor antagonists, sodium
cromoglycate, and splatast tosylate has been reported (19-21).
Because the symptoms were sustained despite leukotriene receptor
antagonists, histamine H1 receptor antagonists, and splatast tosylate
administration before hospitalization, their effect was insufficient
in our case.
In conclusion, this report highlights the utility of elimination
diets in improving the symptoms and subsequent reintroduction in
identifying EGE-causative foods. To date, reports supporting the
utility of elimination diets in patients with EGE have only been
retrospective studies or case reports (10, 22). Further studies are
needed to validate its robustness and efficacy.
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